NEW YORK, March 21, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Performance Sports Group Ltd. (“PSG” or the “Company”) (NYSE:PSG) between August 27, 2015 and March 7, 2016.
You are hereby notified that a securities class action has been commenced in the USDC for the Central District of California, Western Division. If you purchased or otherwise acquired PSG securities between August 27, 2015 and March 7, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/performance-sports-group.
The lawsuit concerns allegations that the Company and its executives violated federal securities laws by failing to disclose the financial pressures on the Company due to Sports Authority’s financial decline and the fall in demand in the softball, baseball and hockey markets.
If you suffered a loss in PSG you have until May 17, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/performance-sports-group.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 



